Maharashtra govt files cases against seven hospitals for reusing medical devices

MUMBAI: The state has lodged cases against seven private and charitable hospitals in the court for the reuse of catheters meant for one time use after sterilizing them as well as charging multiple patients for the same. The courts issued summons to the accused in all seven cases, minister of state (FDA) Madan Yerawar told the state council on Tuesday.

The FDA in April last year had revealed the findings of an inquiry on the use of balloon catheters and guiding catheters by 8 hospitals between March and May 2017.

Cases were subsequently lodged against Fortis Hospital in Mulund, Hiranandani Health Care in Vashi, Platinum Hospital in Mulund, Wockhardt Heart Hospital in Nagpur, Sahyadri Hospital in Pune, Marathwada Medical and Research Institute, Kamalnayan Bajaj Hospital in Aurangabad and BSES Hospital in Andheri, Yerawar said.

The FDA was inquiring into charges that the hospitals were reusing these although the label said they were meant for one-time use. The FDA officials said the devices, after single use, were sent to the pharmacy for charging on the in-patient bill. Later, these devices were sent to the central sterile supply department where they were sterilized using ethylene oxide.

“We reused catheters only for poor patients and didn’t charge them. There are hundreds of references that state that catheters can be reused till it works well,” said Charu Apte, chairman of Sahyadri group of Hospitals.

  • Related Posts

    Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

    Association of Indian Medical Device Industry (AiMeD) sends SOS to Union Minister Piyush Goel New Delhi: The war tremors have started shaking the domestic medical device industry perched on the…

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Dr D S Rana, Chairman, Sir Ganga Ram Trust Society was Cynosure of all Eyes New Delhi: Inaugural Conference of Critical Nephrology Society of India CNSICON 26 under the aegis…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise